Abstract:Neuronopathic Gaucher disease (nGD) is an inherited neurodegenerative disease caused by mutations in GBA1 gene and is associated with premature death. Neuroinflammation plays a critical role in disease pathogenesis which is characterized by microgliosis, reactive astrocytosis, and neuron loss, although molecular mechanisms leading to neuroinflammation are not well-understood. In this report, we developed a convenient tool to quantify microglia proliferation and activation independently and uncovered abnormal proliferation of microglia (∼2-fold) in an adult genetic nGD model. The nGD-associated pattern of inflammatory mediators pertinent to microglia phenotypes was determined, showing a unique signature favoring pro-inflammatory chemokines and cytokines. Moreover, highly polarized (up or down) dysregulations of mTORC1 signaling with varying lysosome dysfunctions (numbers and volume) were observed among three major cell types of nGD brain. Specifically, hyperactive mTORC1 signaling was detected in all disease-associated microglia (Iba1high) with concurrent increase in lysosome function. Conversely, the reduction of neurons presenting high mTORC1 activity was implicated (including Purkinje-like cells) which was accompanied by inconsistent changes of lysosome function in nGD mice. Undetectable levels of mTORC1 activity and low Lamp1 puncta were noticed in astrocytes of both diseased and normal mice, suggesting a minor involvement of mTORC1 pathway and lysosome function in disease-associated astrocytes. These findings highlight the differences and complexity of molecular mechanisms that are involved within various cell types of the brain. The quantifiable parameters established and nGD-associated pattern of neuroinflammatory mediators identified would facilitate the efficacy evaluation on microgliosis and further discovery of novel therapeutic target(s) in treating neuronopathic Gaucher disease.

The Role of GM130 in Nervous System Diseases

A Negative Regulator of Synaptic Development: MDGA and Its Links to Neurodevelopmental Disorders

Ganglioside GM1 and Central Nervous System Diseases

Loss of the Golgin GM130 Causes Golgi Disruption, Purkinje Neuron Loss, and Ataxia in Mice

Repulsive Guidance Molecule-a and Central Nervous System Diseases

GM130-silencing may aggravate blood-brain barrier damage and affect microglia polarization by down-regulating PD-L1 expression after experimental intracerebral hemorrhage

Insights into the Pathobiology of GM1 Gangliosidosis from Single-Nucleus Transcriptomic Analysis of CNS Cells in a Mouse Model

A Distinct Golgi-targeting Mechanism of Dgm130 in Drosophila Neurons.

The role of the Golgi apparatus in disease (Review)

Mechanisms of microRNA-132 in central neurodegenerative diseases: A comprehensive review

The Role of Glycogen Synthase Kinase 3 Beta in Neurodegenerative Diseases

Glycoprotein NMB: an Emerging Role in Neurodegenerative Disease

Golgi Apparatus and Neurodegenerative Diseases

Insights into molecular and cellular functions of the Golgi calcium/manganese-proton antiporter TMEM165

Advances in molecular mechanisms and therapeutic strategies for central nervous system diseases based on gut microbiota imbalance

HMGB1 in nervous system diseases: A common biomarker and potential therapeutic target

A Multifaceted Evaluation of Microgliosis and Differential Cellular Dysregulation of Mammalian Target of Rapamycin Signaling in Neuronopathic Gaucher Disease

Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network

Multifaceted roles of DLG3/SAP102 in neurophysiology, neurological disorders and tumorigenesis

Role of GTPases in the Regulation of Mitochondrial Dynamics in Alzheimer’s Disease and CNS-Related Disorders

HMGB1 in Development and Diseases of the Central Nervous System